Video description: epigenetic clocks and intrinsic capacity at a 2026 summit session
The description says Dr. David Furman's Milan Longevity Summit 2026 session covers epigenetic clocks as tools to measure intrinsic capacity, combining epigenetics, systems immunology, artificial intelligence and large human data. [1]
Automatic summary · not editorially reviewed
The key findings
The description says the session explores epigenetic clocks and how they can be used to measure intrinsic capacity, defined there as combined physical and mental abilities determining healthy ageing. [1]
The description says researchers integrate epigenetics, systems immunology, artificial intelligence and large-scale human data to develop tools for assessing biological age and predicting health trajectories. [1]
The description names Dr. David Furman as Director of the Stanford 1,000 Immunomes Project and Associate Professor at the Buck Institute for Research on Aging. [1]
The source at a glance
- Study type / format
- Video description of a conference session
- Population / context
- A summit session by Dr. David Furman as described in the video description
- Summary based on
- Creator description
- Original publication
- August 8, 2026
Described session topic: clocks and intrinsic capacity
According to the description, the session sits within a track on measuring ageing with biomarkers, clocks and predictive tools. Dr. David Furman is said to explore the emerging science of epigenetic clocks and how they can be used to measure intrinsic capacity. The description defines intrinsic capacity as the combination of physical and mental abilities that determines healthy ageing. It frames the session around predicting how well we will age, not just how long we will live.
Supporting source [1]
Described approach: combining immunology, AI and human data
The description states that researchers are integrating epigenetics, systems immunology, artificial intelligence and large-scale human data. It says they are developing tools to assess biological age, predict health trajectories and identify opportunities for earlier, more personalised interventions. It further says the discussion highlights how these innovations could transform preventive medicine by shifting focus from treating disease to maintaining lifelong function and resilience. These are described aims and possibilities, not reported results.
Supporting source [1]
Described speaker role and summit framing
The description identifies Dr. David Furman as Director of the Stanford 1,000 Immunomes Project and Associate Professor at the Buck Institute for Research on Aging. It says his research focuses on molecular mechanisms of immune ageing and on biomarkers intended to predict healthspan, resilience and disease risk through precision medicine. It also says the Milan Longevity Summit brings together leaders across science, medicine, policy, business, technology and society to rethink health through a One Health perspective linking people, planet and economies.
Supporting source [1]
How to interpret this
This is only the video description; the video and transcript were not reviewed. It reports planned topics and aims, not study designs, samples, results or verified outcomes.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Milan Longevity Summit · youtube.com · August 8, 2026